InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: dmlcento post# 52342

Wednesday, 06/24/2015 10:35:43 AM

Wednesday, June 24, 2015 10:35:43 AM

Post# of 426493
I highly doubt JZ said "we don't know why this works". Even if he said the exact same words, it doesn't excuse the FDA to carry out its basic function, i.e., apply the concept of risk/benefit analysis on Vascepa for ANCHOR approval. If FDA can't do that, then it's pretty much useless.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News